Combination of cyclosporin A and buthionine sulfoximine (BSO) as a pharmacological strategy for circumvention of multidrug resistance in small cell lung cancer cell lines selected for resistance to doxorubicin.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples